Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Net Income (2020 - 2025)

Caribou Biosciences has reported Net Income over the past 6 years, most recently at -$28.5 million for Q4 2025.

  • Quarterly Net Income rose 26.81% to -$28.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$148.3 million through Dec 2025, up 10.97% year-over-year, with the annual reading at -$148.1 million for FY2025, 0.66% up from the prior year.
  • Net Income was -$28.5 million for Q4 2025 at Caribou Biosciences, up from -$29.4 million in the prior quarter.
  • Over five years, Net Income peaked at -$13.2 million in Q1 2021 and troughed at -$47.6 million in Q2 2025.
  • The 5-year median for Net Income is -$30.0 million (2022), against an average of -$30.2 million.
  • Year-over-year, Net Income plummeted 664.48% in 2021 and then surged 44.86% in 2023.
  • A 5-year view of Net Income shows it stood at -$18.5 million in 2021, then tumbled by 65.47% to -$30.6 million in 2022, then fell by 22.45% to -$37.4 million in 2023, then dropped by 3.83% to -$38.9 million in 2024, then increased by 26.81% to -$28.5 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Net Income are -$28.5 million (Q4 2025), -$29.4 million (Q3 2025), and -$47.6 million (Q2 2025).